NCT04818151View on ClinicalTrials.gov

Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data

CompletedOBSERVATIONAL

Enrollment

14,914

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions

Venous Thromboembolic DiseaseKidney Failure, Chronic

Interventions

DRUG

Warfarin

Warfarin treatment for VTE

DRUG

Apixaban

Apixaban treatment for VTE

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT04818151 - Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data | Biotech Hunter | Biotech Hunter